PubMed Health⌕ Search

Biomedical subjects

R D Stiteler

Publications and source records attributed to R D Stiteler.

4 recordsLinked to original sources

Electron field within an electron field treatment of the scalp or other curved surfaces.

The treatment of a curved surface is a challenge for radiation therapy. This patient had previous treatment with electrons to the "skull cap" area for malignant melanoma. The current task was to design a treatment schema to include the rest of the scalp while avoiding the skull cap. Opposing lateral 6-MeV electron fields were used, as well as two anterior 6-MeV electron fields, one field within the other, to produce an acceptable radiation dose to the tumor volume.

Aged↗

Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.

The iv injection of two forms of glucan (DiLuzio and Yamamura), Corynebacterium parvum, or bacillus Calmette-Guérin (BCG) caused a significant increase in the rate and extent of clearance of subsequently injected radiolabeled T1699 carcinoma cells from the lungs of syngeneic DBA2 mice. Dose-response curves were obtained for each agent, the relative rates of clearance of radiolabeled cells were established, and preliminary sequential comparative studies were undertaken. The optimum dose for C. parvum appeared to be lower than for DiLuzio glucan which appeared to be lower than for Yamamura glucan or BCG. The results indicated that at optimum doses one form of glucan (DiLuzio) was as effective as C. parvum and more effective than BCG or a second form of glucan (Yamamura), with respect to the time for the genesis, the magnitude, and the length of time of the response. Very preliminary experiments with a highly malignant and poorly immunogenic cell line of B16 melanoma in syngeneic C57BL/6J mice demonstrated a correlation between an increased level of clearance of radiolabeled cells and a reduced number of subsequent macroscopic lung tumor nodules.

Animals↗

Gonadal shield.

A secondary gonadal shield for use in the pelvic irradiation of males was designed and built using material and apparatus available with the Cerrobend blocking system. The gonadal dose was reduced to approximately 1.5 to 2.5% of the given dose.

Hodgkin Disease↗